June 6, 2017 08:56 AM EDT
Pharma

AM­RI fetch­es $922M in the lat­est CRO pri­vate eq­ui­ty buy­out

John Carroll

Editor & Founder

There’s an­oth­er pri­vate eq­ui­ty deal to re­port on from the CRO front.

Al­bany, NY-based AM­RI $AM­RI an­nounced Tues­day morn­ing that it is be­ing bought out …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Am­gen an­nounces hold on Phase 1 obe­si­ty can­di­date, pipeline cuts

GSK de­fi­ant against vac­cine chal­lenges, will pri­or­i­tize oth­er growth ar­eas

No­vo Nordisk sees growth slow­ing this year, plans Ca­griSe­ma fil­ing for 2026

Pfiz­er says it has at least $10B avail­able for deals in 2025, with a fo­cus on pipeline

New study will try to stop Alzheimer’s decades be­fore it be­gins, us­ing ex­per­i­men­tal Eli Lil­ly drug

Drug­mak­ers seize on bio­mark­ers to test the FDA's rare dis­ease shift

A service from the Financial Times